Morgan SJ, Coulter E, Betts HL, Solomon GM, et al. Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment. J Clin Invest 2024;134:e184171.
PMID: 39235967